AGITG Trial News
AGITG Trial news: The AGITG currently has fifteen studies open to recruitment and four studies in... Read More
AGITG Trial Updates December 2019
NEO-CREATE becomes the second AGITG Endorsed Study The pilot study NEO-CREATE has become the second AGITG... Read More
MODULATE reaches over 75% of its recruitment target
The MODULATE study, led by Prof Niall Tebbutt, is investigating the effectiveness, safety and tolerability of nivolumab with... Read More
Macquarie Bank colleagues invest in cancer research
Employees at Macquarie Bank were out in full force to support GI cancer research last Thursday night, raising... Read More
November 2019: Trial Updates
First site opens for MASTERPLAN The MASTERPLAN trial for pancreatic cancer patients has opened its first site at... Read More
GCCTI Workshop Report
Summary provided by Associate Professor Jeanne Tie. The Genomic Cancer Clinical Trials Initiative (GCCTI) works to support the... Read More
Dr Sharon Pattison awarded Research Fellowship
Dr Sharon Pattison has been awarded the 2019 New Zealand Society of Oncology Roche Translational Cancer Research Fellowship. Dr... Read More
Challenging the Enigmatic Nature of GI Cancers – ASM 2019
The 2019 Annual Scientific Meeting (ASM) of Australasian Gastro-Intestinal Trials Group (AGITG) convened by Dr Lorraine Chantrill, Medical... Read More
Member engagement in fundraising
The GI Cancer Institute is focussed on raising awareness of GI cancers and of AGITG research, and on... Read More
Announcing the 2019 AGITG Award Winners
The 2019 AGITG Annual Scientific Meeting was held from 21-23 August. At the meeting, seven awards were presented... Read More
Dr Yu Jo Chua presents at JSMO
Dr Yu Jo Chua gave a presentation on the AGITG at the Japanese Society of Medical Oncology Annual... Read More
Latrobe Regional Hospital opens as a primary site for DYNAMIC-Rectal
Latrobe Regional Hospital (LRH), located in the regional area of Gippsland, Victoria, is set to open as a... Read More
LIBERATE trial could be key to accurate cancer mutation screening
The LIBERATE study has reached its target of 100 participants, and is now in follow up. LIBERATE is... Read More
RoLaCaRT: Could using robots lead to more successful surgeries?
Using a robot rather than keyhole surgery could lead to a higher rate of successful surgeries for people... Read More
GI Oncology Highlights from ASCO
Comments have been provided by Associate Professor Mustafa Khasraw. POLO This was a phase III trial which found that... Read More
Recruitment strategy revised for NABNEC
Trial update: NABNEC The NABNEC trial is almost halfway to its accrual target, with 31 participants at the end... Read More
June 2019: An update from CEO Russell Conley
Dear Members, At the beginning of this month I attended the ASCO Annual Meeting in Chicago. At the meeting... Read More
Preliminary results for ALT-GIST released
The preliminary results of the ALT-GIST clinical trial were released at the ASCO Annual Meeting. ALT-GIST was a phase... Read More
May 2019: An update from the CEO
Dear Members, Monday 20 May was International Clinical Trials Day. This was an opportunity to reflect on the dedication... Read More